Experience of one UK site presenting a closer examination of safety and efficacy of Anakinra (Kineret®) in systemic juvenile idiopathic arthritis

被引：0
|
作者：
P Livermore
P Woo
机构：
[1] Great Ormond Street Children's Hospital,
来源：
Pediatric Rheumatology | / 6卷 / Suppl 1期
关键词：
Public Health; Arthritis; Juvenile Idiopathic Arthritis; Median Duration; Systemic Feature;
D O I：
10.1186/1546-0096-6-S1-P32
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Safety and Efficacy Evaluation of PerkinRA in Comparison with Kineret in Systemic Juvenile Idiopathic Arthritis Patients
    Mirzaee, Azadeh Zeinab
    Sadeghi, Setayesh
    Shiari, Reza
    Ziaee, Vahid
    Karagah, Amirhossein
    Sinaei, Reza
    Ghotbabadi, Shabnam Hajiani
    Tahghighi, Fatemeh
    Fathi, Mohammad Reza
    Shirvani, Armin
    Miremarati, Aye
    Ghasemi, Leila
    Rahmani, Khosro
    Araghi, Shahram
    Parvaneh, Vadood Javadi
    Jaffaraghaei, Morteza
    Mohammadkarim, Alireza
    BIOMEDICAL AND BIOTECHNOLOGY RESEARCH JOURNAL, 2024, 8 (03): : 363 - 368
  • [2] EFFICACY AND SAFETY OF ANAKINRA IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS - DATA OF THE BIKER REGISTRY
    Klein, Ariane
    Atemnkeng, Veronika Ntam
    Dressler, Frank
    Foeldvari, Ivan
    Kuester, Rolf Michael
    Hospach, Toni
    Ganser, Gerd
    Minden, Kirsten
    Foell, Dirk
    Weller-Heinemann, Frank
    Kuemmerle-Deschner, Jasmin
    Huegle, Boris
    Rietschel, Christoph
    Lilienthal, Eggert
    Horneff, Gerd
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 976 - 976
  • [3] Anakinra in systemic juvenile idiopathic arthritis - The intermountain west experience.
    Zeft, Andrew S.
    Schlesinger, Margaret
    Bohnsack, John
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S682 - S682
  • [4] Anakinra in Systemic Juvenile Idiopathic Arthritis: A Single-center Experience
    Pardeo, Manuela
    Marafon, Denise Pires
    Insalaco, Antonella
    Bracaglia, Claudia
    Nicolai, Rebecca
    Messia, Virginia
    De Benedetti, Fabrizio
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (08) : 1523 - 1527
  • [5] The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis
    Swart, Joost Frans
    Barug, Daantje
    Mohlmann, Michelle
    Wulffraat, Nico M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (12) : 1743 - 1752
  • [6] Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis, the first Chinese experience
    Lingzhi Qiu
    Le Ma
    Yifan Xie
    Jing Jin
    Yuting Pan
    Shumin Li
    Zhidan Fan
    Haiguo Yu
    Pediatric Rheumatology, 22
  • [7] Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis, the first Chinese experience
    Qiu, Lingzhi
    Ma, Le
    Xie, Yifan
    Jin, Jing
    Pan, Yuting
    Li, Shumin
    Fan, Zhidan
    Yu, Haiguo
    PEDIATRIC RHEUMATOLOGY, 2024, 22 (01)
  • [8] A twelve-week open label safety and efficacy study of anakinra (KINERET®) in juvenile rheumatoid arthritis
    Ilowite, NT
    Porras, O
    Reiff, A
    Rudge, SR
    Punaro, MG
    Martin, AL
    Allen, R
    Harville, TO
    Kazazi, F
    Zhou, L
    Newmark, R
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 87 - 87
  • [9] Long-term Safety Profile of Anakinra in Patients with Systemic Juvenile Idiopathic Arthritis
    Giancane, Gabriella
    Papa, Riccardo
    Vastert, Sebastiaan
    Bagnasco, Francesca
    Swart, Joost
    Quartier, Pierre
    Anton, Jordi
    Paut, Isabelle Kone
    Kamphuis, Sylvia
    Herlin, Troels
    Sanner, Helga
    De Benedetti, Fabrizio
    Tsitsami, Elena
    Nielsen, Susan Mary
    Moreno, Estefania
    Pallotti, Chiara
    Franck-Larsson, Karin
    Malmstrom, Hakan
    Cederholm, Susanna
    Raat, Nico Wulff
    Ruperto, Nicolino
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [10] Safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis
    Horneff G.
    Huppertz I.
    Haas P.
    Minden K.
    Ganser G.
    Hospach A.
    Trauzeddel R.
    Pediatric Rheumatology, 13 (Suppl 1)
12345